-+ 0.00%
-+ 0.00%
-+ 0.00%

GENPREX ANNOUNCES IP AUSTRALIA'S INTENT TO GRANT PATENT FOR REQORSA® GENE THERAPY IN COMBINATION WITH PD-L1 ANTIBODIES TO TREAT CANCERS

Reuters·02/10/2026 13:00:09

Please log in to view news